| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
15.760 |
Evidence |
O
|
| KIF3B |
KIF3B, KIAA0359: Kinesin-like protein KIF3B |
KIF3A |
KIF3A, KIF3: Kinesin-like protein KIF3A |
15.760 |
Evidence |
O
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
15.530 |
Evidence |
O
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
APEX1 |
APEX1, APE, APEX, APX, HAP1, REF1: DNA-(apurinic or apyrimidinic site) lyase |
15.410 |
Evidence |
O
|
| LIG1 |
LIG1: DNA ligase 1 |
CDK2 |
CDK2: Cell division protein kinase 2 |
15.410 |
Evidence |
O
|
| INHBB |
INHBB: Inhibin beta B chain precursor |
ACVR1 |
ACVR1, ACVRLK2: Activin receptor type-1 precursor |
15.280 |
Evidence |
O
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
15.200 |
Evidence |
O
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
15.200 |
Evidence |
O
|
| CSPG6 |
SMC3, BAM, BMH, CSPG6, SMC3L1: Structural maintenance of chromosomes protein 3 |
CCT8 |
CCT8: Uncharacterized protein CCT8 |
15.150 |
Evidence |
O
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
15.120 |
Evidence |
O
|
| CD5 |
CD5, LEU1: T-cell surface glycoprotein CD5 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
15.090 |
Evidence |
O
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
15.080 |
Evidence |
O
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
NMI |
NMI: N-myc-interactor |
14.960 |
Evidence |
O
|
| GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB7 |
RAB7A, RAB7: Ras-related protein Rab-7a |
14.880 |
Evidence |
O
|
| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
PSMD7 |
PSMD7, MOV34L: 26S proteasome non-ATPase regulatory subunit 7 |
14.880 |
Evidence |
O
|
| FSHB |
FSHB: Follitropin subunit beta precursor |
CGB |
CGB, CGB3, CGB5, CGB7, CGB8: Choriogonadotropin subunit beta precursor |
14.730 |
Evidence |
O
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
CRKL |
CRKL: Crk-like protein |
14.690 |
Evidence |
O
|
| C1QA |
C1QA: Complement C1q subcomponent subunit A precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
14.620 |
Evidence |
O
|
| PLG |
PLG: Plasminogen precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
14.580 |
Evidence |
O
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
14.450 |
Evidence |
O
|
| IEF-SSP-9502 |
PWP1: Periodic tryptophan protein 1 homolog |
NOC2L |
NOC2L: Nucleolar complex protein 2 homolog |
14.450 |
Evidence |
O
|
| TNFRSF10D |
TNFRSF10D, DCR2, UNQ251/PRO288, TRAILR4, TRUNDD: Tumor necrosis factor receptor |
TNFSF10 |
TNFSF10: Uncharacterized protein TNFSF10 |
14.280 |
Evidence |
O
|
| KCNJ2 |
KCNJ2, HIRK1: Inward rectifier potassium channel 2 |
KCNJ8 |
KCNJ8: ATP-sensitive inward rectifier potassium channel 8 |
14.280 |
Evidence |
O
|
| KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
14.170 |
Evidence |
O
|
| UBE2A |
UBE2A, RAD6A: Ubiquitin-conjugating enzyme E2 A |
RAD18 |
RAD18, RNF73: E3 ubiquitin-protein ligase RAD18 |
14.130 |
Evidence |
O
|
